Ignite Creation Date:
2024-05-06 @ 6:25 PM
Last Modification Date:
2024-10-26 @ 2:47 PM
Study NCT ID:
NCT05657470
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2022-12-02
Brief Title:
Rescue Thrombolysis for Medium Vessel Occlusion RESCUE-TNK
Sponsor:
General Hospital of Shenyang Military Region
Organization:
General Hospital of Shenyang Military Region
Study Overview
Official Title:
Rescue Thrombolysis for Medium Vessel Occlusion RESCUE-TNK a Prospective Randomized Open-label Blinded End Point and Multicenter Trial
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The best reperfusion strategy for medium-sized vessel occlusion MeVO is not well established Given the proven treatment effect of intra-arterial thrombolysis in patients with large vessel occlusion LVO the investigators hypothesized that intra-arterial tenecteplase TNK could increase the recanalization rate of MeVO and thus improve clinical outcome The current study aimed to explore the safety and efficacy of intra-arterial TNK in patients with MeVO
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None